Announcement on Serious Abnormal Fluctuations in Stock Trading
Filed with SSE · · 4 pages · Chinese
Beijing Hotgen Biotech Co. Ltd. on 6ix
Earlier from Beijing Hotgen Biotech
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Capital Increase of Joint Stock Company and Related Party Transactions
- Announcement on Convening Performance Briefing for 2025 and Q1 2026
- Announcement on Progress and Implementation Result of Shares Repurchase and Share Changes
- Announcement on Canceling Some Restricted Stocks Granted and Not Yet Vested
Later from Beijing Hotgen Biotech
- Announcement on Early Termination of the Repurchased Shares Sale Plan and the Results of the Sale of Repurchased Shares
- Announcement on Initial Share Repurchase by the Company via Call Auction
- Announcement on Shareholding of Top 10 Shareholders and Top 10 Shareholders Without Sales Restrictions Concerning Share Repurchase
- Announcement on Progress in Repurchasing Shares
- Announcement on Voluntary Disclosure of Obtaining the "Drug Clinical Trial Approval Notice" for Subsidiary’s Innovative Drug SGT003 Injection
Follow Beijing Hotgen Biotech into a list and get an email when it puts out news.
Follow Beijing Hotgen Biotech